Listed

Autoliv Inc: Form 10-Q for the period ended Mar 31, 2026

Filed with the SEC on Apr 17, 2026 and accepted by EDGAR at Apr 17, 2026, 09:27 ET.

Share

Management's discussion and analysis

As filed, 45,218 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis should be read in conjunction with our Condensed Consolidated Financial Statements and accompanying Notes thereto included elsewhere herein and with our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the United States Securities and Exchange Commission (the “SEC”) on February 19, 2026. Unless otherwise noted, all dollar amounts are in millions.

Autoliv, Inc. (“Autoliv” or the “Company”) is a Delaware corporation with its principal executive offices in Stockholm, Sweden. The Company functions as a holding corporation and owns two principal operating subsidiaries, Autoliv AB and Autoliv ASP, Inc.

Through its operating subsidiaries, Autoliv is a supplier of automotive safety systems with a broad range of product offerings, including modules and components for passenger and driver airbags, side airbags, curtain airbags, seatbelts, steering wheels, and pedestrian protection systems.

Autoliv’s filings with the SEC, including this Quarterly Report on Form 10-Q, annual reports on Form 10-K, current reports on Form 8-K, proxy statements, and all of our other reports and statements, and amendments thereto, are available free of charge on our corporate website at www.autoliv.com (http://www.autoliv.com) as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC (generally the same day as the filing).

The primary exchange market for Autoliv’s securities is the New York Stock Exchange ("NYSE") where Autoliv’s common stock trades under the symbol “ALV”. Autoliv’s Swedish Depositary Receipts ("SDRs") are traded on Nasdaq Stockholm’s list for large market cap companies under the symbol “ALIV SDB”. Options in SDRs trade on Nasdaq Stockholm under the name “Autoliv SDB”. Options in Autoliv shares are traded on Nasdaq OMX PHLX and on NYSE Amex Options under the symbol “ALV”.

Autoliv’s fiscal year ends on December 31.

Non-U.S. GAAP financial measures

Some of the following discussions refer to non-U.S. GAAP financial measures: see reconciliations for “Organic sales,” “Free operating cash flow,” “Cash conversion,” “Net debt,” “Leverage ratio,” “Adjusted net income,” “Adjusted operating income,” “Adjusted operating margin,” “Adjusted other non-operating items,net,” “Adjusted earnings per share, diluted,” “Adjusted return on capital employed,” and “Adjusted return on total equity” provided below. Management believes that these non-U.S. GAAP financial measures provide supplemental information to investors regarding the performance of the Company’s business and assist investors in analyzing trends in the Company's business. Additional descriptions regarding management’s use of these financial measures are included below. Investors should consider these non-U.S. GAAP financial measures in addition to, rather than as substitutes for, financial reporting measures prepared in accordance with U.S. GAAP. These historical non-U.S. GAAP financial measures have been identified as applicable in each section of this report with a tabular presentation reconciling them to the most directly comparable U.S. GAAP financial measures. It should be noted that these measures, as defined, may not be comparable to similarly titled measures used by other companies.

EXECUTIVE OVERVIEW

The first quarter turned out better than we had anticipated, with strong sales in March. Our operational performance exceeded our expectations, with solid productivity improvements, partly supported by reduced call-off volatility. Underlying profitability improved, with gross profit increasing by 10%, although adjusted operating income (Non-GAAP measure, see reconciliation table below) was slightly lower due to temporary lower R,D&E reimbursements and the one-time income in Q1 last year.

Our positive trend in Asia continued, with strong growth in India, South Korea and China. In China, we continued to grow faster than LVP, especially with the Chinese OEMs, outperforming by 40pp. In India, we grew sales organically (Non-GAAP measure, see reconciliation table below) by 38%, reflecting mainly the trend of increased safety content in vehicles in India, as well as the continued high level of LVP growth. We continue to expand our production capabilities in India, investing in additional inflator production capacity for future growth.

We are pleased that we in the quarter introduced our first airbag for motorcycles, as well as our first wearable airbag solution for motorcycle riders, building on our long term strategy of growing business outside our traditional core business.

The quarter was characterized by ongoing and new geopolitical challenges. At this point, it is difficult to fully assess the likely impacts, as the situation remains fluid. We continue to carefully monitor the developments while preparing for various scenarios, including different mitigation strategies.

The business environment is uncertain but our current best estimate for the remainder of the year is a re-iteration of our full year 2026 guidance of about unchanged organic sales (Non-GAAP measure) and an adjusted operating margin (Non-GAAP measure) of around 10.5-11%. This is based on the assumption that LVP will decline by around 1%.

Our balance sheet is healthy, with debt leverage (Non-GAAP measure, see reconciliation table below) of 1.3x, well below our target limit of 1.5x. Based on our guidance for sales and adjusted operating margin, we continue to expect strong cash flow for the year, which supports our ambitions to provide attractive shareholder returns, including to repurchase shares of $300-500 million in 2026.

Financial highlights in the three months period ended March 31, 2026

Change figures below compare to the same period of the previous year, except when stated otherwise.

  • $2,753 million net sales, increase of 6.8%
  • 0.8% organic sales growth (Non-GAAP measure, see reconciliation table below)
  • 8.6% operating margin, 8.9% adjusted. operating margin (Non-GAAP measure, see reconciliation table below)
  • $1.88 diluted EPS, 12% decrease

Key business developments in the three months period ended March 31, 2026

Change figures below compare to the same period of the previous year, except when stated otherwise.

  • Net sales increased organically (Non-GAAP measure, see reconciliation table below) by 0.8%, which was 4.2pp higher than the global LVP decrease of 3.4% (S&P Global, April 2026) driven mainly by strong progress in Asia. Regional and customer LVP mix is estimated to have impacted sales positively by about 1.5pp, while tariff compensations added around 0.5pp. Our organic sales growth (Non-GAAP measure) outperformed LVP significantly in China (15pp) and Asia excl. China (6.8pp) and performed in line in EMEA and underperformed in Americas (4.5pp). Our strong performance in Asia excl. China was mainly due to India, where we outperformed by 28pp, driven by continued strong market growth in safety content per vehicle, while our China performance was mainly driven by further improved presence with Chinese OEMs.
  • Profitability was strong. Supported by successful execution of cost reductions and positive foreign currency effects, gross profit increased by 10%. Operating income decreased by 6.7% and adjusted operating income (Non-GAAP measure, see reconciliation table below) decreased by 3.9%, impacted by adverse foreign currency translation effects and temporary lower R,D&E reimbursements as well as that Q1 2025 was positively impacted by one-time effects. Operating margin was 8.6% and adjusted operating margin (Non-GAAP measure, see reconciliation table below) was 8.9%. ROCE was 22.2% and adjusted ROCE (Non-GAAP measure, see reconciliation table below) was 22.9%.
  • Operating cash flow was negative $76 million, mainly due to an increase in working capital due to strong sales in March, temporary effects expected to reverse later in the year and the high level of accounts payable at the end of 2025. Free operating cash flow (Non-GAAP measure, see reconciliation table below) thereby decreased to negative $159 million. The leverage ratio (Non-GAAP measure, see reconciliation table below) was unchanged compared to a year ago at 1.3x, below our target limit of 1.5x. In the quarter, a dividend of $0.87 per share was paid.

Business and market condition update

Supply Chain

Call-off volatility improved somewhat compared to both Q4 2025 and Q1 2025, although it still remains higher than pre-pandemic levels. Low customer demand visibility and changes to customer call-offs with short notice continued to have some negative impact on our production efficiency and profitability. We expect call-off volatility for the full year 2026 on average to be slightly improved compared to 2025 but still remain higher than pre-pandemic levels. However, the continued significant uncertainty in the geopolitical environment and future changes in tariffs and trade restrictions may lead to more negative call-off volatility.

Raw material inflation, geopolitical risks and tariffs

Raw material price changes had only a small negative impact on our profitability in the first quarter, with a gross impact of around $5 million. For the full year 2026, our current assessment is for around $90 million gross impact from higher raw material prices. We expect to be able to mitigate a majority of this headwind, mainly through internal cost reductions, material mix improvements and commercial negotiations with customers and suppliers. Given the continued uncertainty in the geopolitical environment, the effects of tariffs and trade restrictions may lead to a more adverse inflation environment. We continue to execute on productivity and cost reduction initiatives to offset these cost pressures.

The effects of the new tariffs imposed in 2025 impacted our profitability negatively in the first quarter 2026. Although we achieved customer compensations for more than 70% of tariff costs, the net effect on operating margin was around 40bps negative, including the dilution effect. While it is our ambition and expectation to continue passing tariff costs on to our customers, there is significant uncertainty as future recovery levels may vary. For the full year 2026, we estimate the tariff-related dilution on operating margin to be similar to the around 20 bps that it was for full year 2025.

We currently do not expect any material impact from the U.S. Supreme Court's ruling that the International Emergency Economic Powers Act did not authorize the imposition of the tariffs in 2025, as our gross exposure is limited to around $25 million and the net exposure is well below $10 million.

Ongoing geopolitical developments, including the hostilities in and around the Persian Gulf, introduce additional uncertainty into the global economic environment. These conditions may affect supply chains, commodity prices, customer demand, and broader market stability. As a result, our current financial guidance reflects the best information available today but may be subject to change should these geopolitical dynamics materially impact our operations or the markets in which we operate.

We continue to closely monitor both geopolitical developments and the tariff policy environment in order to be agile to adjust our commercial and operational responses to any such developments.

RESULTS OF OPERATIONS

Overview

The following table shows some of the key ratios management uses internally to analyze the Company's current and future financial performance and core operations as well as to identify trends in the Company’s financial conditions and results of operations. The Company has provided this information to investors to assist in meaningful comparisons of past and present operating results and to assist in highlighting the results of ongoing core operations. These ratios are more fully explained below and should be read in conjunction with the consolidated financial statements in the Company's Annual Report on Form 10-K and the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

The Company's management uses the Return on capital employed (ROCE) and Return on total equity (ROE) measures for purposes of comparing its financial performance with the financial performance of other companies in the industry and providing useful information regarding the factors and trends affecting the Company’s business. As used by the Company, ROCE is annualized operating income and income from equity method investments relative to average capital employed. The Company believes ROCE is a useful indicator of long-term performance both absolute and relative to the Company's peers as it allows for a comparison of the profitability of the Company’s capital employed in its business relative to that of its peers.

ROE is the ratio of annualized income (loss) relative to average total equity for the periods presented. The Company’s management believes that ROE is a useful indicator of how well management creates value for its shareholders through its operating activities and its capital management.

KEY RATIOS

(Dollars in millions, except per share data)

Three Months Ended or As of March 31, 2026 2025
Receivables outstanding relative to sales, %1) 22.0% 21.4%
Inventory outstanding relative to sales, %2) 8.6% 8.9%
Payables outstanding relative to sales, %3) 16.9% 17.8%
Gross margin, %4) 19.1% 18.6%
Operating margin, %5) 8.6% 9.9%
Capital employed6) 4,417 4,149
Net debt7) 1,773 1,787
Return on total equity, %8) 21.7% 28.8%
Return on capital employed, %9) 22.2% 25.6%
Headcount at period-end10) 64,100 65,900

1) Outstanding receivables relative to annualized quarterly sales.

2) Outstanding inventory relative to annualized quarterly sales.

3) Outstanding payables relative to annualized quarterly sales.

4) Gross profit relative to sales.

5) Operating income relative to sales.

6) Total equity and net debt.

7) Net debt adjusted for pension liabilities in relation to EBITDA. See tabular presentation reconciling this non-U.S. GAAP measure to U.S. GAAP below.

8) Net income relative to average total equity.

9) Operating income and income from equity method investments, relative to average capital employed.

10) Employees plus temporary, hourly personnel.

three months period ended March 31, 2026 COMPARED WITH three months period ended March 31, 2025

Consolidated Sales Development

(dollars in millions)

Three Months Ended March 31, 2026 2025 Reported change Components of change in net sales Currency effects 1) Organic 3)
Airbags, Steering Wheels and Other2) $1,863 $1,752 6.3% 5.6% 0.7%
Seatbelt products and Other2) 890 826 7.8% 6.7% 1.1%
Total $2,753 $2,578 6.8% 6.0% 0.8%
Americas $863 $851 1.3% 6.5% (5.2)%
EMEA 835 764 9.3% 11.1% (1.8)%
Asia excl. China 563 515 9.3% (1.8)% 11.1%
China 492 447 10.0% 5.1% 4.9%
Total $2,753 $2,578 6.8% 6.0% 0.8%

1) Effects from currency translations.

2) Including Corporate sales.

3) Non-U.S. GAAP measure.

Sales by product - Airbags, Steering Wheels and Other

Sales for Airbags, Steering Wheels and Other grew organically (Non-U.S. GAAP measure, see reconciliation table above) by 0.7% in the quarter. The largest contributors to the increase were center airbags, driver airbags and side airbags, partly offset by declines for passenger airbags and inflatable curtains.

Sales by product - Seatbelts and Other

Sales for Seatbelt Products and Other grew organically (Non-U.S. GAAP measure, see reconciliation table above) by 1.1% in the quarter. Sales increased organically in Asia excluding China, EMEA and China while sales declined in Americas.

Sales by region

Our global organic sales (Non-U.S. GAAP measure, see reconciliation table above) increased by 0.8% compared to the global LVP decrease of 3.4% (according to S&P Global, April 2026). The relative performance was positively impacted by product launches but also by positive effects from the regional and model LVP mix development, which we estimate contributed to about 1.5pp outperformance and by tariff compensations of around 0.5pp. Our organic sales growth (Non-U.S. GAAP measure) outperformed LVP growth by 15pp in China and by 6.8pp in Asia excluding China. We performed in line with LVP in EMEA and underperformed by 4.5pp in Americas, impacted mainly by negative mix due to a high LVP growth in low content South America and a lower content on some replacement models.

LVP in China declined substantially with global OEMs declining by 8.5% and Chinese OEMs declining by 11%. Our sales to domestic OEMs increased by around 30% while our sales to global OEMs decreased by around 10%. We expect continued strong sales growth in China in 2026, driven mainly by our performance with domestic OEMs. Our strong sales growth in Asia excluding China was mainly due to 38% organic sales growth (Non-U.S. GAAP measure, see reconciliation table above) in India, reflecting LVP growth but mainly the trend of increased safety content in vehicles in India.

First quarter of 2026 organic growth1)

Americas EMEA Asia excl. China China Global
Autoliv (5.2)% (1.8)% 11.1% 4.9% 0.8 %
Main growth drivers Subaru, Stellantis Renault, Volvo Suzuki, Tata Chery, EV COEM Suzuki, Chery
Main decline drivers Ford, GM VW, Hyundai Toyota, Subaru VW, Honda Ford, VW

1) Non-U.S. GAAP measure.

Light Vehicle Production Development

Change first quarter of 2026 versus first quarter of 2025

Americas EMEA Asia excl. China China Global
LVP1) (0.6)% (0.8)% 4.3 % (10.1)% (3.4)%

1) Source: S&P Global, April 2026.

Earnings

(Dollars in millions, except per share data)

Three Months Ended March 31, 2026 2025 Change
Net Sales $2,753 $2,578 6.8%
Gross profit 526 478 10.0%
% of sales 19.1% 18.6% 0.6 pp
S, G&A (161) (145) 11.1%
% of sales (5.8)% (5.6)% (0.2 )pp
R, D&E, net (120) (95) 26%
% of sales (4.3)% (3.7)% (0.7 )pp
Other income (expense), net (9) 15 n/a
Operating income 237 254 (6.7)%
% of sales 8.6% 9.9% (1.2 )pp
Adjusted operating income1) 245 255 (3.9)%
% of sales 8.9% 9.9% (1.0 )pp
Financial and non-operating items, net (35) (22) 60.7%
Income before taxes 202 233 (13.1)%
Income taxes (60) (65) (7)%
Tax rate 29.9% 28.0% 1.9 pp
Net income 142 167 (15.4)%
Earnings per share, diluted2) 1.88 2.14 (12)%
Adjusted earnings per share, diluted1,2) 2.05 2.15 (5)%

1) Non-U.S. GAAP measure, excluding effects from capacity alignments and antitrust related matters.

2) Net of treasury shares.

First quarter of 2026 financial development

Gross profit increased by $48 million and gross margin increased by 0.6pp compared to the prior year. The drivers behind the gross profit improvement were mainly positive foreign currency effects, improved operational efficiency with lower costs for labor as well as positive effects from higher sales. This was partly offset by increased tariff costs, net.

S,G&A costs increased by $16 million compared to the prior year, mainly due to $10 million in negative foreign currency translation effects and $5 million in higher costs for personnel driven by wage inflation and a non-recurring cost of $4 million. S,G&A costs in relation to sales increased from 5.6% to 5.8%.

R,D&E, net, costs increased by $25 million compared to the prior year, mainly due to $11 million in lower engineering income related to timing effects, $5 million in higher personnel costs due to wage inflation and $4 million in negative FX translation effects. R,D&E, net, in relation to sales increased from 3.7% to 4.3%.

Other income (expense), net, was negative $9 million, compared to positive $15 million in the same period last year. The positive $15 million in 2025 related mainly to recycled accumulated currency translation differences related to the divestment of our idled operations in Russia while the negative $9 million in 2026 related mainly to restructuring costs in EMEA.

Operating income decreased by $17 million compared to the prior year, due to the higher costs for R,D&E, net, Other income (expense) and S,G&A, partly offset by higher gross profit as outlined above.

Adjusted operating income (Non-U.S. GAAP measure, see reconciliation table below) decreased by $10 million compared to the prior year, due to the higher costs for R,D&E, net, S,G&A and Other income (expense), partly offset by higher gross profit as outlined above.

Financial and non-operating items, net, was negative $35 million compared to negative $22 million a year earlier. The cost increase comes from $12 million in higher costs for non-operating items mainly related to restructuring costs in Americas.

Income before taxes decreased by $30 million compared to the prior year, mainly due to the lower operating income and higher costs for financial and non-operating items, net.

Tax rate was 29.9% compared to 28.0% the prior year. Discrete tax items, net, had an unfavorable impact of 2.3pp in the first quarter 2026, while discrete tax items, net were not material in the corresponding quarter last year.

Earnings per share, diluted decreased by $0.26 compared to the prior year. The main drivers were $0.16 from lower operating income, $0.12 from financial and non-operating items, $0.05 from taxes partly offset by $0.07 from lower number of outstanding shares, diluted.

LIQUIDITY AND CAPITAL RESOURCES

The Company does not have any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on its financial position, results of operations or cash flows. The Company’s future contractual obligations have not changed materially from the amounts reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 19, 2026.

First quarter of 2026 development

Changes in operating working capital impacted operating cash flow by $349 million negative compared to an impact of $179 million negative in the prior year. The $349 million increase in operating working capital mainly comes from $175 million increase in receivables and $134 million decrease in accounts payables. The increase in operating working capital is mainly related to high level of sales in March 2026, other temporary effects that are expected to reverse later in the year and the high level of accounts payable at the end of December 2025.

Operating cash flow decreased by $153 million to $(76) million compared to the prior year, mainly because of the increase in operating working capital outlined above and a lower net income, partly offset by higher depreciation and other non-cash adjustments.

Capital expenditure, net, decreased by $10 million compared to the prior year. The level of capital expenditure, net, in relation to sales declined to 3.0% versus 3.6% a year earlier. The lower level of capital expenditure, net is mainly related to the lower activity level of footprint optimization and less capacity expansion.

Free operating cash flow (Non-U.S. GAAP measure, see reconciliation table below) was negative $159 million compared to negative $16 million in the prior year. The decrease was due to the lower operating cash flow partly offset by the lower capital expenditure, net, as outlined above.

Cash conversion (Non-U.S. GAAP measure, see reconciliation table below) defined as free operating cash flow (Non-U.S. GAAP measure) in relation to net income, was n/a in the quarter compared to n/a a year earlier as free operating cash flow was negative both quarters.

Net debt (Non-U.S. GAAP measure, see reconciliation table below) was $1,773 million as of March 31, 2026, which was $14 million lower than a year earlier.

Total equity as of March 31, 2026, increased by $283 million compared to March 31, 2025. This was mainly due to net income of $710 million and $103 million in positive currency translation effects, partly offset by $304 million in share repurchases, including taxes, and $249 million in dividend payments.

Leverage ratio (Non-U.S. GAAP measure, see reconciliation table below): On March 31, 2026, the Company had a leverage ratio of 1.3x compared to 1.3x on March 31, 2025, as the 12 months trailing adjusted EBITDA (Non-U.S. GAAP measure, see reconciliation table below) increased by $74 million while net debt (Non-U.S. GAAP measure) per the policy was unchanged. Our target is to have a leverage ratio not higher than 1.5x.

NON-U.S. GAAP MEASURES

The Company believes that comparability between periods is improved through the exclusion of certain items. To assist investors in understanding the operating performance of Autoliv's business, it is useful to consider certain U.S. GAAP measures exclusive of these items.

The following tables reconciles Income before income taxes, Net income attributable to controlling interest and Capital employed, which are inputs utilized to calculate Return On Capital Employed (“ROCE”), adjusted ROCE, Return On Total Equity (“ROE”), and adjusted ROE. The Company believes this presentation may be useful to investors and industry analysts who utilize these adjusted non-U.S. GAAP measures in their ROCE and ROE calculations to exclude certain items for comparison purposes across periods. Autoliv’s management uses the ROCE, adjusted ROCE, ROE and adjusted ROE measures for purposes of comparing its financial performance with the financial performance of other companies in the industry and providing useful information regarding the factors and trends affecting the Company’s business.

As used by the Company, ROCE is annualized operating income and income from equity method investments, relative to average capital employed. Adjusted ROCE is annualized operating income and income from equity method investments, relative to average capital employed as adjusted to exclude certain non-recurring items. See definitions of "annualized operating income" and "average capital employed" in footnote to the tables below. The Company believes ROCE and adjusted ROCE are useful indicators of long-term performance both absolute and relative to the Company's peers as it allows for a comparison of the profitability of the Company’s capital employed in its business relative to that of its peers.

ROE is the ratio of annualized income (loss) relative to average total equity for the periods presented. See definitions of "annualized income" "and "average total equity" in footnote to the tables below. Adjusted ROE is annualized income (loss) relative to average total equity for the periods presented as adjusted to exclude certain non-recurring items. The Company’s management believes that ROE and adjusted ROE are useful indicators of how well management creates value for its shareholders through its operating activities and its capital management.

Accordingly, the tables below reconcile from U.S. GAAP to the equivalent non-U.S. GAAP measure.

Reconciliation of GAAP measure "Operating income" to Non-GAAP measure "Adjusted Operating income"

(Dollars in millions)

Three Months Ended March 31, 2026 2025
Operating income (GAAP) $237 $254
Non-GAAP adjustments:
Less: Capacity alignments 8 2
Less: Antitrust related items 0 (1)
Total non-GAAP adjustments to operating income 8 1
Adjusted Operating income (Non-GAAP) $245 $255

Reconciliation of GAAP measure "Operating margin" to Non-GAAP measure "Adjusted Operating margin"

Three Months Ended March 31, 2026 2025
Operating margin (GAAP) 8.6% 9.9%
Non-GAAP adjustments:
Less: Capacity alignments 0.3% 0.1%
Less: Antitrust related items 0.0% (0.0)%
Total non-GAAP adjustments to operating margin 0.3% 0.0%
Adjusted Operating margin (Non-GAAP) 8.9% 9.9%

Reconciliation of GAAP measure "Other non-operating items, net" to Non-GAAP measure "Adjusted Other non-operating items, net"

(Dollars in millions)

Three Months Ended March 31, 2026 2025
Other non-operating items, net (GAAP) $(12) $0
Non-GAAP adjustments:
Less: Capacity alignments - non-operating1) 9 -
Total non-GAAP adjustments to Other non-operating items, net 9 -
Adjusted Other non-operating items, net (Non-GAAP) $(3) $0
1) Relates to curtailment loss in connection with restructuring and capacity alignment activities.

Reconciliation of GAAP measure "Income before income taxes" to Non-GAAP measure "Adjusted Income before income taxes"

(Dollars in millions)

Three Months Ended March 31, 2026 2025
Income before income taxes (GAAP) $202 $233
Non-GAAP adjustments:
Less: Capacity alignments - operating 8 2
Less: Capacity alignments - non-operating1) 9 -
Less: Antitrust related items 0 (1)
Total non-GAAP adjustments to Income before income taxes 17 1
Adjusted Income before income taxes (Non-GAAP) $219 $233
1) Relates to curtailment loss in connection with restructuring and capacity alignment activities.

24

Reconciliation of GAAP measure "Net income" to Non-GAAP measure "Adjusted Net income"

(Dollars in millions)

Three Months Ended March 31, 2026 2025
Net income (GAAP) $142 $167
Non-GAAP adjustments:
Less: Capacity alignments - operating 8 2
Less: Capacity alignments - non-operating1) 9 -
Less: Antitrust related items 0 (1)
Less: Tax on non-GAAP adjustments (4) (0)
Total non-GAAP adjustments to Net income 12 1
Adjusted Net income (Non-GAAP) $154 $168
1) Relates to curtailment loss in connection with restructuring and capacity alignment activities.

Reconciliation of GAAP measure "Net income attributable to controlling interest" to Non-GAAP measure "Adjusted Net income attributable to controlling interest"

(Dollars in millions)

Three Months Ended March 31, 2026 2025
Net income attributable to controlling interest (GAAP) $141 $167
Non-GAAP adjustments:
Less: Capacity alignments - operating 8 2
Less: Capacity alignments - non-operating1) 9 -
Less: Antitrust related items 0 (1)
Less: Tax on non-GAAP adjustments (4) (0)
Total non-GAAP adjustments to Net income attributable to controlling interest 12 1
Adjusted Net income attributable to controlling interest (Non-GAAP) $154 $167
1) Relates to curtailment loss in connection with restructuring and capacity alignment activities.

Reconciliation of GAAP measure "Earnings per share - diluted" to Non-GAAP measure "Adjusted Earnings per share - diluted"

(Per share data) Three Months Ended March 31, 2026 2025
Earnings per share - diluted (GAAP) $1.88 $2.14
Non-GAAP adjustments:
Less: Capacity alignments - operating 0.10 0.02
Less: Capacity alignments - non-operating1) 0.12 -
Less: Antitrust related items 0.00 (0.02)
Less: Tax on non-GAAP adjustments (0.05) (0.00)
Total non-GAAP adjustments to Earnings per share - diluted 0.17 0.01
Adjusted Earnings per share - diluted (Non-GAAP) $2.05 $2.15
Weighted average number of shares outstanding - diluted 75.1 77.9
1) Relates to curtailment loss in connection with restructuring and capacity alignment activities.

25

Reconciliation of GAAP measure "Return on Capital Employed" to Non-GAAP measure "Adjusted Return on Capital Employed"

Three Months Ended March 31, 2026 2025
Return on capital employed1) (GAAP) 22.2% 25.6%
Non-GAAP adjustments:
Less: Capacity alignments - operating 0.7% 0.2%
Less: Antitrust related items 0.0% (0.1)%
Total non-GAAP adjustments to Return on capital employed1) 0.7% 0.1%
Adjusted Return on capital employed1) (Non-GAAP) 22.9% 25.6%
Annualized adjustment2) on Return on capital employed1) $31 $3
1) Annualized operating income and income from equity method investments, relative to average capital employed. The average capital employed amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period.
2) The quarterly annualized adjustment to the operating income and income from equity method investments amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the operating income and income from equity method investments amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four.

Reconciliation of GAAP measure "Return on Total Equity" to Non-GAAP measure "Adjusted Return on Total Equity"

Three Months Ended March 31, 2026 2025
Return on total equity1) (GAAP) 21.7% 28.8%
Non-GAAP adjustments:
Less: Capacity alignments - operating 1.1% 0.3%
Less: Capacity alignments - non-operating2) 1.3% -
Less: Antitrust related items 0.0% (0.2)%
Less: Tax on non-GAAP adjustments (0.6)% (0.0)%
Total non-GAAP adjustments to Return on total equity1) 1.9% 0.1%
Adjusted Return on total equity1) (Non-GAAP) 23.5% 28.9%
Annualized adjustment3) on Return on total equity1) $50 $2
1) Annualized net income relative to average total equity. The average total equity amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period.
2) Relates to curtailment loss in connection with restructuring and capacity alignment activities.
3) The quarterly annualized adjustment to net income amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the net income amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four.

Autoliv from time to time enters into “debt-related derivatives” (DRDs) as a part of its debt management and as part of efficiently managing the Company’s overall cost of funds. Creditors and credit rating agencies use net debt adjusted for DRDs in their analyses of the Company’s debt, therefore we provide this non-U.S. GAAP measure. DRDs are fair value adjustments to the carrying value of the underlying debt. Also included in the DRDs is the unamortized fair value adjustment related to a discontinued fair value hedge that will be amortized over the remaining life of the debt. By adjusting for DRDs, the total financial liability of net debt is disclosed without grossing debt up with currency or interest fair values.

Reconciliation of U.S. GAAP financial measure to “Net debt”

(Dollars in millions)

March 31, 2026 December 31, 2025 March 31, 2025
Short-term debt $393 $419 $540
Long-term debt 1,699 1,734 1,565
Total debt 2,091 2,153 2,105
Cash and cash equivalents (342) (604) (322)
Debt issuance cost/Debt-related derivatives, net 23 17 4
Net debt $1,773 $1,566 $1,787

26

The non-U.S. GAAP measure “Net debt” is also used in the non-U.S. GAAP measure “Leverage ratio”. Management uses the non-U.S. GAAP measure “Leverage Ratio” to analyze the amount of debt the Company can incur under its debt policy. Management believes that this policy also provides guidance to credit and equity investors regarding the extent to which the Company would be prepared to leverage its operations. The Company's long-term target for the leverage ratio (sum of net debt plus pension liabilities divided by EBITDA) is 1.0x with the aim to operate within the range of 0.5x to 1.5x. For details and calculation of leverage ratio, refer to the table below.

Calculation of “Leverage ratio”

(Dollars in millions)

(Dollars in millions)

March 31, 2026 December 31, 2025 March 31, 2025
Net debt1) $1,773 $1,566 $1,787
Pension liabilities 176 169 163
Net debt per the Policy 1,949 1,736 1,950
Net income2) 710 736 688
Income taxes 2) 246 250 246
Interest expense, net2,3) 93 93 97
Other non-operating items, net2) 28 15 16
Income from equity method investments2) (6) (6) (6)
Depreciation and amortization of intangibles2) 419 407 386
Capacity alignments2) 28 23 19
Antitrust related items2) 4 3 4
Other items2) — — (0)
EBITDA per the Policy (Adjusted EBITDA) $1,523 $1,521 $1,449
Leverage ratio 1.3 1.1 1.3

1) Net debt (non-U.S. GAAP measure) is short- and long-term debt and debt-related derivatives, less cash and cash equivalents.

2) Latest 12-months.

3) Interest expense, net including cost for extinguishment of debt, if any, less interest income.

Management uses the non-U.S. GAAP measure “free operating cash flow” to analyze the amount of cash flow being generated by the Company’s operations after capital expenditure, net. This measure indicates the Company’s cash flow generation level that enables strategic value creation options such as dividends or acquisitions. For details on the calculation of free operating cash flow, see the table below. Management uses the non-U.S. GAAP measure “cash conversion” to analyze the proportion of net income that is converted into free operating cash flow. The measure is a tool to evaluate how efficiently the Company utilizes its resources. For details on cash conversion, see the table below.

Reconciliation of GAAP measure "Operating cash flow" to "Free operating cash flow" and "Cash conversion"

(Dollars in millions)

Three Months Ended March 31, 2026 2025
Net income $142 $167
Changes in operating working capital (349) (179)
Depreciation and amortization 107 95
Gain on divestiture of property — (6)
Other, net 25 (1)
Operating cash flow (76) 77
Expenditures for property, plant and equipment (85) (102)
Proceeds from sale of property, plant and equipment 1 8
Capital expenditure, net1) (84) (93)
Free operating cash flow2) $(159) $(16)
Cash conversion3) n/a n/a
1) Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment.
2) Operating cash flow less Capital expenditures, net.
3) Free operating cash flow relative to Net income.

27

Headcount

March 31, 2026 December 31, 2025 March 31, 2025
Total headcount 64,100 64,300 65,900
Whereof:
Direct personnel in manufacturing 46,700 47,300 48,800
Indirect personnel 17,400 17,000 17,100
Temporary personnel 10% 10% 10%

As of March 31, 2026, total headcount (Full Time Equivalent) decreased by around 1,900, or 2.9%, compared to a year earlier. The indirect workforce increased by around 300, or 1.5%, mainly reflecting a change in headcount reporting classification, moving around 300 people from direct to indirect. The direct workforce decreased by approximately 2,100, or 4.4%. The decrease was supported by an improvement in customer call-off accuracy which enabled us to accelerate operating efficiency improvements and also reflecting the reclassification mentioned above.

Compared to December 31, 2025, total headcount (Full Time Equivalent) decreased by around 200, or 0.4%. Indirect headcount increased by around 300, while direct headcount decreased by approximately 600 impacted by the reclassification mentioned above.

Full year 2026 guidance

In addition to the assumptions below and in our business and market update below, our full year 2026 guidance is based on our customer call-offs and the achievement of our targeted cost compensation adjustments with our customers, including no material changes to tariffs or trade restrictions, as compared to what is in effect as of April 10, 2026, as well as no significant changes in the macro-economic environment, changes to customer call-off volatility or significant supply chain disruptions.

Full year 2026 Guidance
Organic sales growth Around 0%
Adjusted operating margin 1) Around 10.5-11%
Operating cash flow 2) Around $1.2 billion
Capital expenditures, net % of sales Less than 5%
1) Excluding effects from capacity alignments, antitrust related matters and other discrete items.
2) Excluding unusual items.
Full year 2026 Assumptions
LVP growth Around 1% negative
Foreign currency impact on net sales Around 3% positive
Tax rate3) Around 28%
3) Excluding unusual tax items.

This report includes content supplied by S&P Global; Copyright © Light Vehicle Production Forecast, January and April 2026. All rights reserved.

The forward-looking non-U.S. GAAP financial measures above are provided on a non-U.S. GAAP basis. The Company has not provided a U.S. GAAP reconciliation of these measures because items that impact these measures, such as costs and gains related to capacity alignments and antitrust matters, cannot be reasonably predicted or determined. As a result, such reconciliation is not available without unreasonable efforts and the Company is unable to determine the probable significance of the unavailable information.

Other Items

  • On February 19, 2026, Autoliv announced that Mr. Martin Lundstedt, a current member of the Board of Directors, has elected not to stand for re-election. Mr. Lundstedt's service as a director will end at the 2026 Annual Stockholders Meeting.
  • On March 6, 2026, Autoliv announced that its Board of Directors appointed Monika Grama as the new Chief Financial Officer and Executive Vice President, Finance, of the Company. Ms. Grama succeeded Fredrik Westin as of April 1, 2026. Ms. Grama has served as the Vice President, Finance of the Autoliv Europe Middle East and Africa (EMEA) division since 2020. Monika Grama joined Autoliv in 2009 and, prior to her current role, she served as Finance Manager and Managing Director of Autoliv Romania, one of Autoliv's largest production hubs globally. Ms. Grama has played a vital role in contributing to the development of the Autoliv EMEA division during a challenging period for the automotive industry.
  • On March 6, 2026, Autoliv announced the renewal for one year of its €3 billion guaranteed euro medium term note program, originally established on April 11, 2019.
  • On March 12, 2026, Autoliv announced it has together with Yamaha Motor Co. co-developed an innovative airbag system for the new Tricity commuter scooter. This is a significant step toward making advanced safety solutions accessible to a wider range of riders, moving beyond their previous availability solely on high-end motorcycles. The collaboration reflects Autoliv's continued expansion beyond its core business and supports the company's long-term strategic direction.
  • On March 24, 2026, Autoliv announced it has developed its first complete wearable protection for motorcycle riders: a vest with an integrated airbag system designed to reduce critical injury risks in the event of a crash. This system is being launched in collaboration with RS Taichi, a leading manufacturer of motorcycle riding gear, who will bring it to market. This initiative complements Autoliv's motorcycle and bike offer and supports its long-term strategy to explore opportunities beyond its core business of airbags, seatbelts and steering wheels for light vehicles.
  • The Board has set Thursday, May 7, 2026 as the date for the 2026 Annual Stockholders Meeting. The Board has decided that the meeting will be in-person only.

Market risk

As filed, 287 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of March 31, 2026, there have been no material changes to the information related to quantitative and qualitative disclosures about market risk that were provided in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on February 19, 2026.

Controls and procedures

As filed, 1,140 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures

An evaluation has been carried out, under the supervision and with the participation of the Company's management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report. Based on such evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company's disclosure controls and procedures are effective.

(b) Changes in Internal Control over Financial Reporting

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Risk factors

As filed, 224 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of March 31, 2026, there have been no material changes to the risk factors that were previously disclosed in Item 1A in the Company’s Form 10-K for the year ended December 31, 2025 filed with the SEC on February 19, 2026.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2026-01-01 to 2026-03-31$2.75bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2026-01-01 to 2026-03-31$2.23bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2026-01-01 to 2026-03-31$526.0mus-gaap:GrossProfit
Research and development3 months2026-01-01 to 2026-03-31$120.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2026-01-01 to 2026-03-31$161.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2026-01-01 to 2026-03-31$237.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2026-01-01 to 2026-03-31$26.0mus-gaap:InterestExpense
Income tax3 months2026-01-01 to 2026-03-31$60.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2026-01-01 to 2026-03-31$141.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2026-01-01 to 2026-03-31$1.88us-gaap:EarningsPerShareDiluted
Basic EPS3 months2026-01-01 to 2026-03-31$1.89us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2026-01-01 to 2026-03-3175,100,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2026-01-01 to 2026-03-31−$76.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2026-01-01 to 2026-03-31$85.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2026-01-01 to 2026-03-31$65.0mus-gaap:PaymentsOfDividendsCommonStock
Cash and equivalentsAt period end2026-03-31$342.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2026-03-31$3.99bnus-gaap:AssetsCurrent
Total assetsAt period end2026-03-31$8.47bnus-gaap:Assets
Current liabilitiesAt period end2026-03-31$3.71bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2026-03-31$1.70bnus-gaap:LongTermDebtNoncurrent
Short-term borrowingsAt period end2026-03-31$393.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2026-03-31$2.63bnus-gaap:StockholdersEquity
Shares outstandingAt period end2026-04-1074,863,338 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001193125-26-160472. Last ingested by Listed: Nov 14, 2026, 11:22 ET. Listed shows no prices and gives no investment advice.